Reduction of ischemic K+ loss and arrhythmias in rat hearts. Effect of glibenclamide, a sulfonylurea

Circulation Research
P F KantorL H Opie

Abstract

Glibenclamide, one of the antidiabetic sulfonylureas, is known to block ATP-dependent K+ channels. We used this drug to determine to what extent K+ loss from acutely ischemic myocardium is mediated via these channels. We also investigated whether glibenclamide would influence ischemic arrhythmias. Isolated rat hearts rendered globally ischemic showed no correlation between early lactate and K+ efflux rates. Cumulative K+ loss during 11 minutes of global ischemia (0.5 ml min-1 g-1) was reduced, from 3.2 +/- 0.3 to 2.5 +/- 0.1 mueq/g (p less than 0.025) by 1 microM glibenclamide and from 3.3 +/- 0.2 to 1.9 +/- 0.2 mueq/g (p less than 0.005) by 10 microM glibenclamide, while lactate efflux was unaltered by the drug. Glibenclamide also exhibited potent antifibrillatory activity, abolishing irreversible ventricular fibrillation during regional ischemia (0/6 vs. 5/6 controls; p less than 0.02) and during global ischemia (0/7 vs. 9/9 controls; p less than 0.01). Heart rate, coronary flow rate, peak systolic pressure, and myocardial oxygen consumption were unaltered by the drug (1 microM). Similarly, glibenclamide (1 microM) did not alter myocardial ATP, phosphocreatine or lactate content, or glucose utilization. Ventricular fibrillati...Continue Reading

References

Apr 15, 1976·Experientia·A Vleugels, E Carmeliet
Mar 1, 1990·Journal of Cardiovascular Pharmacology·L ChiB R Lucchesi
Nov 1, 1986·Pflügers Archiv : European journal of physiology·G TrubeT Ohno-Shosaku
Nov 1, 1986·Pflügers Archiv : European journal of physiology·M J Dunne, O H Petersen
Aug 1, 1987·Pflügers Archiv : European journal of physiology·B BellesG Trube
Oct 1, 1987·Journal of Molecular and Cellular Cardiology·A G KléberM J Janse
Aug 1, 1989·Journal of Molecular and Cellular Cardiology·C D WollebenP K Siegl
Oct 1, 1986·Journal of Molecular and Cellular Cardiology·W F LubbeJ Pybus
Apr 1, 1987·Journal of Molecular and Cellular Cardiology·M J CurtisM J Walker
Dec 1, 1987·Cardiovascular Research·T CrakeP A Poole-Wilson
Feb 1, 1972·Canadian Journal of Physiology and Pharmacology·G W Mainwood, G E Lucier
Aug 1, 1973·Journal of Molecular and Cellular Cardiology·P P Mathur, R B Case
Jan 1, 1971·Cardiology·R B Case
Jun 1, 1966·American Heart Journal·A S Harris
Jun 1, 1967·American Heart Journal·B Surawicz
May 1, 1984·Journal of Molecular and Cellular Cardiology·A G Kléber
May 1, 1982·Journal of Molecular and Cellular Cardiology·H KammermeierE Jüngling
Oct 1, 1980·Circulation Research·A VleugelsE Carmeliet

❮ Previous
Next ❯

Citations

Apr 1, 1996·Clinical Cardiology·V DucceschiA Iacono
Oct 15, 1998·Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine·N B RadfordA D Sherry
Aug 1, 1990·Cardiovascular Drugs and Therapy·L H Opie
Dec 1, 1994·Cardiovascular Drugs and Therapy·R N Gasser, W Klein
Aug 1, 1993·Cardiovascular Drugs and Therapy·J N Weiss, N Venkatesh
Aug 1, 1993·Cardiovascular Drugs and Therapy·L H Opie
Aug 1, 1993·Cardiovascular Drugs and Therapy·A A Wilde
Mar 1, 1995·Cardiovascular Drugs and Therapy·W HaverkampG Breithardt
Feb 17, 1993·Molecular and Cellular Biochemistry·L VirágM Hiraoka
Jul 1, 1996·Diabetes Research and Clinical Practice·A Lomuscio, C Fiorentini
Jul 1, 1996·Diabetes Research and Clinical Practice·A Végh, J G Papp
Oct 1, 1993·Journal of the American College of Cardiology·S BekheitN el-Sherif
Jun 28, 2005·Journal of Molecular and Cellular Cardiology·Thomas P Flagg, Colin G Nichols
Aug 26, 2000·European Journal of Pharmacology·W A CoetzeeM Avkiran
May 12, 2001·European Journal of Pharmacology·A J WorkmanB J Northover
Dec 5, 1996·European Journal of Pharmacology·Y X WangX B Zhou
Apr 4, 1997·European Journal of Pharmacology·A FukunariT Nakajima
Feb 13, 1999·European Journal of Pharmacology·N E El-ReyaniJ G Papp
Aug 10, 1999·European Journal of Pharmacology·T TangA K Ho
Aug 23, 2002·Pharmacology & Therapeutics·Alan Wickenden
Apr 30, 1998·Journal of the American College of Cardiology·P A Brady, A Terzic
Feb 25, 2003·Cardiovascular Pathology : the Official Journal of the Society for Cardiovascular Pathology·Koichi KawaharaYoshiko Yamauchi
Jan 28, 2003·Comparative Biochemistry and Physiology. Part A, Molecular & Integrative Physiology·Tyson J MacCormackWillam R Driedzic
Mar 12, 2010·The New England Journal of Medicine·Barry J Maron, N A Mark Estes
Dec 1, 1992·British Journal of Pharmacology·H SakutaY Watanabe
Nov 4, 2000·Journal of Cardiovascular Electrophysiology·D S HolmesW A Coetzee
Apr 1, 1992·Pharmacology & Toxicology·K E Andersson

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.